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OBJECTIVE — Toassesstheassociationof1,5-anhydroglucitol(1,5-AG)with2-hpostpran-
dial glucose values in type 2 diabetic patients followed over 12 months in an outpatient setting.
RESEARCH DESIGN AND METHODS — In 55 patients, we examined self-measured
postprandial blood glucose values for correlations with 1,5-AG values over prespeciﬁed preced-
ing time periods (3 days, 1 week, and weekly up to 12 weeks).
RESULTS — The correlation coefﬁcients for postprandial glucose values were 0.34 (P 
0.05) for 3 days , 0.38 (P  0.001) for 1 week, and 0.40 (P  0.001) for 2 weeks preceding
the measurement of 1,5-AG. Correlations declined for time periods 2 weeks before measure-
mentof1,5-AG.Thecorrelationwaslowerwithfasting/preprandialplasmaglucoselevels.There
was no time dependency for the correlation between A1C and fasting or postprandial glucose.
CONCLUSIONS — 1,5-AG best reﬂected the 2-h postprandial glucose values of the 2 pre-
vious weeks.
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R
ecent studies found 1,5-anhydro-
glucitol (1,5-AG) to generally re-
ﬂect postprandial hyperglycemia
(1–4).However,thesestudieswerecross-
sectional, had a comparably short follow-
up (1,2,4), or included patients in the
pre-diabetic state (3). The present study
assessed the correlation of 2-h postpran-
dial glucose measurements, frequently
recommended in clinical practice, with
1,5-AG and aimed at deﬁning the time
interval of glucose values yielding the
closest correlation with 1,5-AG in dia-
betic patients.
RESEARCH DESIGN AND
METHODS— This was a prospective
studyatthreelargeSwisshospitalsassess-
ing the impact of strategies to improve
postprandial glucose by optimizing the
combination of oral antidiabetes drugs
and/or insulin according to a prespeciﬁed
scheme (5). Included patients had type 2
diabetes 6 months with A1C between
7.0 and 12.0%. Patients with renal insuf-
ﬁciency or proteinuria were excluded.
Written consent was obtained, and the
study was approved by the local ethics
committees. The study duration was 12
months with clinical visits every 3
months. Patients regularly monitored
their blood glucose levels before and 2 h
after main meals (Glucotrend Premium;
Roche Diagnostics, Mannheim, Ger-
many), and 1,5-AG was measured at each
time point in a central laboratory (Lana
1.5 Auto Liquid Reagent; InterBiotech,
Tokyo, Japan; automated on a Hitachi
917 Analyzer, coefﬁcient of variation
5.2%). A1C was measured on a DCA
2000 (Bayer, Leverkusen, Germany).
Postprandial glucose values were in-
cluded in the analysis if measured be-
tween 110 and 130 min after the
corresponding preprandial measure-
ment.Correlationcoefﬁcientswerecalcu-
lated using standardized linear
regression. In sensitivity analyses, the
models were adjusted for age, sex, treat-
ment modalities, time in study, and time
ofday.1,5-AGmeasurementswereexam-
ined for correlations with postprandial
glucose values taken over the following
prespeciﬁed preceding time periods: 3
days, 1 week, then weekly up to 12
weeks. All analyses were performed using
Stata 10.0 (Stata, College Station, TX).
RESULTS— All 55 patients (19
women and 36 men) contributed to the
present analysis. The mean age was
61.3  9.6 years (mean  SD). The aver-
age number of self-measurements of
blood glucose per patient and year were
405  224 (fasting/preprandial) and
230  122 (postprandial). Mean fasting/
preprandial glucose was 155  48 mg/dl
at the beginning and 133  46 mg/dl at
the end of the study, and corresponding
values for postprandial glucose were
17255and16253mg/dl.MeanA1C
was 8.7  1.3% at baseline and 7.7 
1.0% at study end. Mean 1,5-AG was
4.23.5g/mlatbaselineand6.43.5
g/mlatstudyend.A1Cand1,5-AGwere
negatively correlated (r  0.42, P 
0.001). The correlation coefﬁcient of
postprandial glucose values with 1,5-AG
varied across the prespeciﬁed time peri-
ods preceding the measurement of
1,5-AG (Fig. 1): 0.34 (P  0.05) for 3
days, 0.38 (P  0.001) for 1 week, and
0.40 (P  0.001) for 2 weeks. After-
ward, the strength of the correlation de-
creased (P  0.001 for all remaining
correlations). The association of fasting/
preprandial glucose and 1,5-AG was
lower (0.19 to 0.23, P  0.001 for all
correlations)anddidnotrevealatimede-
pendency (Fig. 1). Adjusting analyses for
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study, and time of day did not change the
observed time dependency (data not
shown). Time-speciﬁc correlation coefﬁ-
cients were 0.26–0.28 for A1C with fast-
ing/preprandial and 0.22–0.30 for A1C
with postprandial glucose, without evi-
dence of a time dependency.
CONCLUSIONS — The present
study is the ﬁrst to longitudinally assess
the association of 1,5-AG with 2-h post-
prandial glucose values in diabetic pa-
tients followed over 12 months in an
outpatient setting. Although correlations
were moderate (0.5 in magnitude),
1,5-AG best reﬂected 2-h postprandial
glucose values in the 2 preceding weeks.
No time dependency resulted for the as-
sociation of fasting glucose values and
1,5-AG. Correlations were weaker for
A1C with fasting/preprandial as well as
with postprandial glucose.
A comparable albeit slightly stronger
correlation of 1,5-AG with postprandial
glucose in a population of type 1 and 2
diabetic patients was recently reported.
Of note, Dungan et al. (1) used a contin-
uous glucose monitoring system to mea-
sure the area under the curve for glucose
levels exceeding 180 mg/dl, while the
presentstudywasbasedonself-measured
glucose values. The lower number of
postprandial compared with preprandial
values reﬂects the difﬁculty to motivate
patients for additional measurements and
substantiates the role of 1,5-AG as a sub-
stitute for postprandial glucose measure-
ments, complementing the widely used
A1C and fructosamine measurements.
A recent cross-sectional study in pre-
diabetic Japanese patients found a higher
correlation with 2-h postprandial glucose
(3).Itisnoteworthythat1,5-AGissubject
to urinary excretion followed by almost
complete reabsorption, which is compet-
itively inhibited by glucose if the renal
threshold for glucosuria is exceeded (6).
While glucosuria in prediabetic individu-
als mainly occurs in the context of carbo-
hydrate loading, diabetic patients may
reveal increased glucose values indepen-
dently of meals. Moreover, differences in
absolute levels of 1,5-AG between Asian
andCaucasianindividualshavebeenpre-
viously reported (7). In conclusion, this
longitudinalstudyinanoutpatientsetting
shows that 1,5-AG best reﬂects 2-h post-
prandialglucosevaluesinthe2preceding
weeks.
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Figure 1—Correlation coefﬁcients and 95% CIs of 1,5-AG with 2-h postprandial glucose values
(Œ)andwithfasting/preprandialglucosevalues(F)forthecorrespondingtimeperiodspreceding
measurement of 1,5-AG (3 days up to 12 weeks).
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